The use of abciximab during percutaneous coronary angioplasty reduces ischaemic events, but the cost is prohibitive

Bibliographische Detailangaben

Veröffentlicht in:	South African medical journal 1998-02, Vol.88 (2), p.130-131
Hauptverfasser:	Mayosi, B M, Latouf, S E, Commerford, P J
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty, Balloon, Coronary - economics Antibodies, Monoclonal - economics Antibodies, Monoclonal - therapeutic use Cost-Benefit Analysis Humans Immunoglobulin Fab Fragments - economics Immunoglobulin Fab Fragments - therapeutic use Myocardial Ischemia - drug therapy Platelet Aggregation Inhibitors - economics Platelet Aggregation Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!